In chronic heart failure (CHF) patients, diuretic administration plays a key role in the control of congestion. However, high diuretic dose (HDD) has been also demonstrated to be associated to a worse prognosis. The aim of this study was to evaluate the factors independently associated to HDD and, in particular, the role of a marker of renal perfusion, the Renal arterial Resistance Index (RRI). We enrolled 250 outpatients (78% males, 64±13 years, NYHA class 2.2±0.6, left ventricular ejection fraction, LVEF, 34±10%) with CHF (ESC criteria) due to left ventricular systolic dysfunction, in stable clinical conditions (> 1 month) and in conventional therapy. All patients underwent: a clinical evaluation to assess NYHA class; a routine chemistry to evaluate NT-proBNP and glomerular filtration rate (GFR) by creatinine (MDRD formula); an echocardiogram to evaluate LVEF and to estimate central venous pressure (CVP); a renal echo-Doppler in order to evaluate RRI. Peak systolic velocity and end diastolic velocity of segmental renal artery was obtained by pulsed Doppler flow and RRI was then calculated. RRI was positively and significantly correlated with furosemide equivalent dose (r: 0.33; p<0.001) and with HDD (r: 0.36; p<0.001). As shown in the In conclusion, our findings help to better understand the wide variability of diuretic dosage, by demonstrating the independent influence of RRI, a parameter reflecting renal arterial resistance. These data could also represent the basis of future studies aimed to optimise therapeutic strategies by improving renal flow and, as a consequence, diuretic response.
In chronic heart failure (CHF) patients, diuretic administration plays a key role in the control of congestion. However, high diuretic dose (HDD) has been also demonstrated to be associated to a worse prognosis. The aim of this study was to evaluate the factors independently associated to HDD and, in particular, the role of a marker of renal perfusion, the Renal arterial Resistance Index (RRI). We enrolled 250 outpatients (78% males, 64±13 years, NYHA class 2.2±0.6, left ventricular ejection fraction, LVEF, 34±10%) with CHF (ESC criteria) due to left ventricular systolic dysfunction, in stable clinical conditions (> 1 month) and in conventional therapy. All patients underwent: a clinical evaluation to assess NYHA class; a routine chemistry to evaluate NT-proBNP and glomerular filtration rate (GFR) by creatinine (MDRD formula); an echocardiogram to evaluate LVEF and to estimate central venous pressure (CVP); a renal echo-Doppler in order to evaluate RRI. Peak systolic velocity and end diastolic velocity of segmental renal artery was obtained by pulsed Doppler flow and RRI was then calculated. RRI was positively and significantly correlated with furosemide equivalent dose (r: 0.33; p<0.001) and with HDD (r: 0.36; p<0.001). As shown in the table, RRI remained significantly associated with HDD in a multivariate logistic regression analysis including the other factors significantly correlated at univariate analysis. In conclusion, our findings help to better understand the wide variability of diuretic dosage, by demonstrating the independent influence of RRI, a parameter reflecting renal arterial resistance. These data could also represent the basis of future studies aimed to optimise therapeutic strategies by improving renal flow and, as a consequence, diuretic response.
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Renal resistance index: a new marker reflecting cardiorenal syndrome independently associated with heart failure progression In chronic heart failure (CHF) patients, renal dysfunction assessed by glomerular filtration rate (GFR) has been demonstrated to be independently associated with higher morbidity and mortality rates. The aim of this study was to define whether a novel marker of renal perfusion impairment (Renal Resistance Index, RRI) could play a role in independently predicting heart failure progression. We enrolled 250 outpatients (78% males, 64±13 years, NYHA class 2.2±0.6, left ventricular ejection fraction, LVEF, 34±10%) with CHF (ESC criteria) due to left ventricular systolic dysfunction, in stable clinical conditions (> 1 month) and in conventional therapy. All patients underwent a clinical evaluation, a routine chemestry, an echocardiogram and a renal echo-Doppler. Pulsed Doppler flow recording was performed at the level of a segmental renal artery and RRI was then calculated from the peak systolic Doppler flow velocity and the end-diastolic Doppler flow velocity. During follow-up (17.8±9.9 months), 37 patients experienced heart failure progression (hospitalization, heart transplantation or death due to heart failure worsening). RRI ≥75% was associated with events at univariate (HR: 6,06, 95% CI: Purpose: Heart failure (HF) affects almost all organs in our body through reduced organ perfusion and resultant neurohumoral alterations. Major depression is more prevalent in HF patients as compared with normal subjects, suggesting the possible interaction between the heart and the brain in HF. However, the mechanism of depressive symptoms in HF remains largely unclear. Several reports showed the association between major depression and structural abnormality of the hippocampus such as grey matter reduction and decreased neurogenesis. In the present study, we thus investigated whether hippocampal grey matter reduction and decreased neurogenesis were observed in association with depressive symptoms in a rat model of HF using magnetic resonance (MR) imaging and histological analysis. Methods: Male Wistar rats were divided into two groups: HF group with permanent ligation of the left coronary artery (n=28) and sham-operated control group (n=25). Four months after the procedure, the following two studies were performed. In the first study, the HF group (n=20) and the sham group (n=17) underwent behavioral tests (open-field test and elevated plus maze test) for assessment of depressive symptoms, followed by structural brain MR image acquisition. The obtained MR images were analyzed to detect regional alterations in grey matter between the two groups as measured by grey matter probability values (a maximum value of 1). In the second study, brains of the both groups (n=8, each) were fixed for histological analysis of neurogenesis by counting the number of bromodeoxyuridine (BrdU) Background: Friedreich's ataxia (FRDA) is a neurodegenerative disorder resulting from deficiency of frataxin, characterized by cardiac hypertrophy, heart failure and sudden cardiac death. However, the relationship between remodeling and novel measures of cardiac function such as strain, and time-dependent changes in these measures are poorly defined.
Methods and results:
We compared echocardiographic parameters of cardiac size, hypertrophy and function in 50 FRDA patients to 50 normal controls. We quantified the following measures of cardiac remodeling and function: left ventricular (LV) volumes, LV mass, relative wall thickness (RWT), ejection fraction (EF) and myocardial strain. Linear regression was used to identify significant differences in echocardiographic parameters in FRDA compared to normals. In analyses adjusted for age, sex, and body surface area, significant differences were observed between parameters of remodeling (LV mass, RWT, and volumes) and function in FRDA patients compared to controls. In particularly, longitudinal strain was significantly decreased in FRDA patients compared to controls (-12.4% versus -16.0%, p<0.001), despite similar and normal LVEF. Over 3 years of followup, there was no change in strain, LV size, LV mass, or LVEF among FRDA patients.
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Conclusion: Longitudinal strain is reduced in FRDA despite normal LVEF, indicative of subclinical cardiac dysfunction. Given late declines in LVEF in FRDA, longitudinal strain may provide an earlier index of myocardial dysfunction in FRDA.
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Long-term therapy with Bendavia (MTP-131), a novel mitochondria-targeting peptide, reverses mitochondrial abnormalities in left ventricular myocardium of dogs with advanced heart failure H.N. Sabbah, R.C. Gupta, S. Rastogi, M. Wang, K. Zhang. Henry Ford Hospital, Detroit, United States of America Background: Mitochondria (MITO) of failed human hearts and hearts of dogs with experimental heart failure manifest functional abnormalities characterized by reduced state-3 respiration, reduced membrane potential ( ψm) and increased opening of membrane permeability transition pores (mPTP). These abnormalities lead to reduced ATP synthesis that adversely impacts LV function. Bendavia (MTP-131), a novel, first in class, MITO-targeting peptide, has been shown to improve LV systolic function in dogs with chronic heart failure and to improve ATP synthesis in multiple organs including heart, kidney and skeletal muscle in other animal models of disease. The present study tested the hypothesis that longterm therapy with Bendavia reverses functional MITO abnormalities in dogs with chronic heart failure. Methods: Studies were performed in cardiomyocytes isolated from LV myocardium of 14 HF dogs produced by intracoronary microembolizations (LV ejection fraction ∼30%). Dogs were randomized to 3 months monotherapy with subcutaneous injections of Bendavia (0.5 mg/kg once daily, n=7) or saline (Control, n=7) . MITO state-3 respiration was measured using a Clark electrode. ψm was measured using the dye JC-1 and mPTP was measured based on the rate of calcein exit from MITO. MITO ATP synthesis was measured using the bioluminescent ApoSENSORTM assay kit. Results: Compared to Control, Bendavia significantly improved MITO state-3 respiration, increased ψm, decreased the rate of calcein exit from MITO thus decreasing mPTP opening and increased in ATP synthesis (Table) . Introduction: Heart failure (HF) is one of the most important chronic diseases that cause quality of life (QoL) impairment. Among other clinical parameters, QoL has been related to heart rate in patients with HF. Objective and methods: To assess the relationship between heart rate determined at first visit and QoL assessed by the Minnesota Living with Heart Failure Questionnaire (MLWHFQ), according to the presence of sinus rhythm or atrial fibrillation. Several statistical analyses were performed: correlation using Spearman rho, Kruskall-Wallis test after dividing heart rate in quartiles, and linear regression of the logarithmic form of both MLWHF score and heart rate. The latter was then adjusted by age, sex, and beta-blocker treatment and in sinus rhythm patients also ivabradine treatment.
Results: 1334 patients were included (960 men and 374 women). Median age was 68 years. LVEF was 31%. Etiology of HF was mainly ischemic heart disease (53.5%), followed my dilated cardiomyopathy (11.7%). Patients were in NYHA functional class I (4.9%), II (63.2%), III (30.1%) and IV (1.6%). 1073 patients (80.4%) were in sinus rhythm and 261 in atrial fibrillation (19.6%). 901 patients (67.5%) were on beta-blocker treatment and 32 (2.4%) on ivabradine. QoL was significantly associated to heart rate in sinus rhythm patients (rho 0.18, p<0.001; Kruskall-Wallis p<0.001; linear regression non-adjusted p<0.001; adjusted linear regression p<0.001). However this was not observed in atrial fibrillation patients (rho 0.05, p=0.46; Kruskall-Wallis p=0.6; linear regression non-adjusted p=0.58; adjusted linear regression p=0.50).
QoL according to heart rate Conclusion: QoL at first visit was significantly related with heart rate in patients with sinus rhythm, but not in patients with atrial fibrillation.
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Nurse-based educational intervention in a heart failure unit improves outcomes in self-care, quality of life and depression of high-risk patients with chronic heart failure S. Lopez-Fernandez, M. Puga-Martinez, M. Jimenez-Fernandez, M.J. MolinaLerma, V. Alcalde-Martinez, E. Lopez-Moreno, R. Melgares-Moreno. University Hospital Virgen de las Nieves, Granada, Spain Purpose: Self-care management is an important part of Heart Failure (HF) treatment. Multidisciplinary management programmes in Heart Failure Units (HFU) have been encouraged by the latest European Guidelines on Chronic HF. However, no clear interventions have been proved to be effective and "tailored" different programmes are used in every country. The purpose of this study was to evaluate the impact of a nurse-based educational intervention (NEI) on quality of life of high-risk patients with Chronic HF. Methods: We included patients admitted at our HFU after a HF episode that required hospitalization from February 2011 to October 2012. After discharge and treatment optimization, patients and their carers were offered a 4-weeks NEI. Patients with motility limitations or no possible self-access to our centre were excluded. Standardized tests to measure performance in activities of daily living, cognitive impairment and co-morbidity were performed. Self-care (The European Heart Failure Self-care Behavior (ESS)), quality of life (Minnesota living with heart failure questionnaire (MQ)) and degree of depression, (Yessavage's Geriatric Scale (YS)) were measured and compared pre and 3 months post-NEI. NEI consisted of four weekly consecutive sessions with brochures and audio-visual support that included topics as promoting self-care, recognition of alarm signs and symptoms, flexible diuretic regimen, diet/regular exercise aspects, pharmacological treatment, importance of psychological aspects etc. Results: From 408 patients visited in our HFU during this time, 107 patients (26%) were included in our NEI. 74% were men, mean age was nearly 70 years (range 43-89 years). Mean left ventricle ejection fraction was 31±8%, 91% were on NYHA class II-III and 97% were on ECA-inhibitors/ARB. Included patients were mostly independent in daily living (Barthel mean score (MS):98,5±5,8), without significant cognitive impairment (Pfeiffer's test MS: 0,94±0,52) and with moderate degree of co-morbidities (Charlson co-morbidity index MS: 5,27±2,27). After NEI, our patients showed a statistically significant improvement in quality of life (MQ MS reduction: 3,79, p<000,1), a better self-care (ESS MS reduction: 6,12, p<0,001) and lesser degree of depression (YS MS reduction: 3,36 p=0,001). Conclusions: NEI improved self-management, quality of life and depression symptoms in patients with Chronic HF. This is an important benefit for this special, high-mortality, easily-decompensated population that can suppose an economical cost-reduction for health-care systems. NEI should be promoted to benefit these patients.
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Disease management program in implementing the guidelines of heart failure C.P. Amorim, R. Bosquetti, E.P.V. Felix, F. Dalpicolo, R.B. Madeo, J. Dinkhuysen, V.S. Issa, F. Ramires. Heart Hospital (HCor), São Paulo, Brazil
Introduction: Heart Failure (HF) is a public health problem around the world with a fast growing prevalence. Optimized treatment has proven to be effective in reducing morbidity and mortality. HF Registers have demonstrated a heterogeneity regarding the application of the Guidelines. Specialized HF clinics results in a improvement of quality of life due to better adherence to the treatment. Regarding hospitalized patients there is no evidence of the benefit of management programs. Our hypothesis is that a hospital management program has a key role in better adherence to current Guidelines. Objective: Evaluate the role of Management Program in HF treatment in hospitalized patients.
Material and methods:
We evaluated 418 patients with HF and ventricular dysfunction (LVEF<45%), divided in two groups: G1-258 hospitalized patients treated in 2010, before the adoption of the program, and G2-160 patients including 346 hospitalization, hospitalized after the implementation of the Program. The Program consist in a trained and specialized multidisciplinary team work-
